The International Atomic Energy Agency is backing plans to keep track of how much medical radiation patients are exposed to over time by issuing smart cards and modifying electronic medical records.
The International Atomic Energy Agency is backing plans to keep track of how much medical radiation patients are exposed to over time by issuing smart cards and modifying electronic medical records.
The IAEA announced April 29 an initiative that relies on imaging equipment vendors and IT experts to develop a long-term radiation exposure record for patients available whenever and wherever they go for a scan. All modalities would have to display the dose delivered in a standardized format, while hospitals and clinics would also need an EMR system that can store individual dose data and produce a running total of lifetime x-ray exposure. Tangible results from the project, which is being funded jointly by the IAEA and the U.S. Nuclear Regulatory Commission, can be expected within the next three to five years.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.